ASHP therapeutic position statement on the use of aspirin for prophylaxis of myocardial infarction

被引：0
作者：
不详
机构：
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 1997年 / 54卷 / 17期
关键词：
American Society of Health-System pharmacists; aspirin; dosage; mechanism of action; myocardial infarction; organizations; patient information; patients; pharmacists; platelet aggregation inhibitors; protocols; sea; toxicity;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1984 / 1987
页数：4
相关论文
共 31 条
[1]   COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[2]  
[Anonymous], 1988, LANCET, V2, P349
[3]   KNOWLEDGE AND PRACTICES OF GENERALIST AND SPECIALIST PHYSICIANS REGARDING DRUG-THERAPY FOR ACUTE MYOCARDIAL-INFARCTION [J].
AYANIAN, JZ ;
HAUPTMAN, PJ ;
GUADAGNOLI, E ;
ANTMAN, EM ;
PASHOS, CL ;
MCNEIL, BJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (17) :1136-1142
[4]  
Braunwald E, 1994, AHCPR PUBLICATION, V94-0602, P1
[5]   INHIBITION OF PLATELET PROSTAGLANDIN SYNTHETASE BY ORAL ASPIRIN [J].
BURCH, JW ;
STANFORD, N ;
MAJERUS, PW .
JOURNAL OF CLINICAL INVESTIGATION, 1978, 61 (02) :314-319
[6]   ASPIRIN, SULFINPYRAZONE, OR BOTH IN UNSTABLE ANGINA - RESULTS OF A CANADIAN MULTICENTER TRIAL [J].
CAIRNS, JA ;
GENT, M ;
SINGER, J ;
FINNIE, KJ ;
FROGGATT, GM ;
HOLDER, DA ;
JABLONSKY, G ;
KOSTUK, WJ ;
MELENDEZ, LJ ;
MYERS, MG ;
SACKETT, DL ;
SEALEY, BJ ;
TANSER, PH .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (22) :1369-1375
[7]   ANTITHROMBOTIC AGENTS IN CORONARY-ARTERY DISEASE [J].
CAIRNS, JA ;
LEWIS, HD ;
MEADE, TW ;
SUTTON, GC ;
THEROUX, P .
CHEST, 1995, 108 (04) :S380-S400
[8]   POSSIBLE SIGNIFICANCE OF SMALL NUMBERS OF FUNCTIONAL PLATELETS IN A POPULATION OF ASPIRIN-TREATED PLATELETS INVITRO AND INVIVO [J].
CERSKUS, AL ;
ALI, M ;
DAVIES, BJ ;
MCDONALD, JWD .
THROMBOSIS RESEARCH, 1980, 18 (3-4) :389-397
[9]   ASPIRIN AND CORONARY HEART-DISEASE - FINDINGS OF A PROSPECTIVE STUDY [J].
HAMMOND, EC ;
GARFINKEL, L .
BMJ-BRITISH MEDICAL JOURNAL, 1975, 2 (5965) :269-271
[10]   ASPIRIN AND PREVENTION OF MYOCARDIAL-INFARCTION [J].
HARTNEY, TJ .
BIOMEDICINE & PHARMACOTHERAPY, 1989, 43 (02) :73-77
1234